Question
A 34-year-old man is brought to the emergency department after being found unconscious at home. On examination, his respiratory rate is 6 breaths/min, oxygen saturation is 86% on air, pulse is 58 beats/min and blood pressure is 102/64 mmHg. His pupils are markedly constricted. Arterial blood gas demonstrates hypercapnia and respiratory acidosis. After intravenous naloxone, his respiratory rate improves to 14 breaths/min, but 40 minutes later he again becomes markedly drowsy with a respiratory rate of 7 breaths/min. His partner reports that he takes methadone regularly.
What is the most appropriate next step in management?
A. Give intravenous flumazenil
B. Intubate immediately without further antidote treatment
C. Start a naloxone infusion with continued respiratory monitoring
D. Give activated charcoal and discharge once conscious
E. Give intravenous sodium bicarbonate
Answer
C. Start a naloxone infusion with continued respiratory monitoring
Explanation
This presentation is typical of opioid toxicity. The classic triad is:
- Miosis — classically pinpoint pupils
- Respiratory depression
- Reduced level of consciousness
The most immediately dangerous feature is respiratory depression. Hypoventilation causes COâ‚‚ retention, producing type 2 respiratory failure with respiratory acidosis on arterial blood gas.
Naloxone is a competitive opioid receptor antagonist and rapidly reverses opioid-induced respiratory depression. The key therapeutic goal is restoration of adequate ventilation rather than complete restoration of consciousness. Naloxone may be given IV or IM and repeated every few minutes according to clinical response; in significant toxicity, airway support and oxygenation are managed simultaneously.
The important clue in this patient is recurrent respiratory depression after an initially successful naloxone dose. Naloxone has a shorter duration of action than many opioids, particularly long-acting preparations such as methadone. Therefore, once naloxone wears off, opioid toxicity can recur.
Repeated naloxone boluses may be required, and patients with recurrent toxicity from long-acting opioids may require a continuous naloxone infusion. They also need prolonged observation because delayed recurrent respiratory depression can occur.
Methadone is especially important because of its long and variable half-life. Patients with methadone or modified-release opioid poisoning may therefore require monitoring for many hours, sometimes at least 24 hours depending on the clinical situation.
A bedside blood glucose should also be checked in any patient with reduced consciousness to exclude hypoglycaemia. Co-ingestion of alcohol, benzodiazepines, antidepressants or other sedative drugs should always be considered if the clinical response is incomplete or atypical.
Flumazenil is not appropriate for opioid poisoning and can precipitate seizures in certain benzodiazepine-related situations. Sodium bicarbonate is principally used for significant sodium-channel blockade, such as tricyclic antidepressant toxicity, rather than uncomplicated opioid toxicity.
Summary for quick exam revision
Opioid poisoning classically presents with the triad of pinpoint pupils, respiratory depression and reduced consciousness. Common causative drugs include heroin, morphine, codeine, methadone and tramadol. The most dangerous manifestation is respiratory depression, which can cause hypoxaemia, hypercapnia and type 2 respiratory failure. Initial management follows an ABC approach with particular attention to airway patency and ventilation. Naloxone is the specific opioid antagonist and should be given when clinically significant respiratory depression is present. Naloxone therapy should be titrated to achieve an adequate respiratory rate and ventilation rather than simply trying to make the patient fully conscious. Repeated doses may be required every few minutes if respiratory depression persists. Naloxone has a substantially shorter duration of action than many opioids, so recurrent toxicity after initial improvement is an important clinical problem. Long-acting opioids, particularly methadone and modified-release preparations, are especially likely to cause recurrent respiratory depression. Patients needing repeated naloxone doses may require a continuous naloxone infusion. Methadone poisoning requires prolonged observation because its effects can persist long after the initial naloxone has worn off. An arterial blood gas may show hypercapnic respiratory acidosis due to hypoventilation. Blood glucose should always be checked in a patient with impaired consciousness to exclude hypoglycaemia. Needle marks may support a diagnosis of injected opioid use but are not necessary for diagnosis. Co-ingestants such as alcohol, benzodiazepines or other sedatives should be considered, particularly when the clinical picture is atypical or the response to naloxone is incomplete. The key exam principle is therefore: opioid toxicity threatens life through respiratory depression, and naloxone should be titrated to ventilation with repeated dosing, infusion and prolonged monitoring when long-acting opioids are involved.